Will small-scale, high-throughput upstream processes become the standard for cell culture development?
This is the question posed by Matthieu Stettler, Manager Upstream Developments at Merck Serono at the Cell Culture World Congress 2012. Matthieu went on to ask; are small-scale technologies capable of advancing the industry further? and can they continue to reduce costs and increase productivity standards?
He completed his presentation with a look at the successful utilisation of multiple small-scale processes to allow access to cell line performance information in reduced time.
Would this insight be useful in optimising your operational procedures? DOWNLOAD the presentation now to gain all of the facts!
Do you want to find out more?
For more updates on pharma, biotech and R&D, follow us on Twitter: @biopharmaevents or join our LinkedIn group: BioPharma- Networking for Pharmaceuticals, Biotech and R&D